| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1001/JAMA.1992.03480240088040 |
| 10.1001/JAMA.267.24.3326 | ||
| P698 | PubMed publication ID | 1534588 |
| P2093 | author name string | A. M. Scanu | |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| risk factor | Q1475848 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 3326-3329 | |
| P577 | publication date | 1992-06-01 | |
| 1992-06-24 | |||
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Lipoprotein(a). A genetic risk factor for premature coronary heart disease | |
| P478 | volume | 267 |
| Q37437244 | C-reactive protein and lipoprotein-a as markers of coronary heart disease in polycystic ovary syndrome |
| Q39578353 | Cardiovascular risk factors of migrants in Port Moresby from the highlands and island villages, Papua New Guinea |
| Q34041484 | Childhood cardiovascular risk factors in South Asians: A cause of concern for adult cardiovascular disease epidemic |
| Q37834033 | Cilostazol and atherogenic dyslipidemia: a clinically relevant effect? |
| Q44442589 | Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors |
| Q80297993 | Complementary medicine for prostate cancer: effects of soy and fat consumption |
| Q38293925 | Complexity of molecular genetics of dyslipidemia in a family highly susceptible to ischemic heart disease |
| Q72378183 | Coronary artery disease is highly prevalent among patients with premature peripheral vascular disease |
| Q50117114 | Correlates of vascular access occlusion in hemodialysis |
| Q46114213 | Did grandma give you heart disease? The new battle against coronary artery disease |
| Q51325589 | Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients. |
| Q33719966 | Effects of exercise on lipoprotein(a). |
| Q42169796 | Effects of rosiglitazone on fasting and postprandial low- and high-density lipoproteins size and subclasses in type 2 diabetes. |
| Q77768777 | Essential hypertension is lymphatic: a working hypothesis |
| Q35170825 | Established and recently identified coronary heart disease risk factors in young people: the influence of physical activity and physical fitness |
| Q80967242 | Gemfibrozil treatment in patients with elevated lipoprotein a: a pilot study |
| Q35643684 | Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. |
| Q40748807 | Global risk assessment for lipid therapy to prevent coronary heart disease |
| Q51552490 | Hypercholesterolemia and Dyslipidemia. |
| Q51537186 | Hypercholesterolemia and Dyslipidemia: Issues for the Clinician. |
| Q71343790 | I/D polymorphism at the locus for ACE and apo A-I gene promoter polymorphism as risk factors for coronary artery disease in patients with familial hypercholesterolemia |
| Q52877795 | Immunoturbidimetric determination of lipoprotein(a): improvement in the measurement of turbid and triglyceride-rich samples |
| Q34118495 | Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level |
| Q35188880 | Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment |
| Q41985047 | Inflammation and dyslipidaemia: a possible interplay between established risk factors in North Indian males with coronary artery disease |
| Q36932254 | Lipid profiles of persons with paraplegia and tetraplegia: sex differences. |
| Q44005130 | Lipoprotein (a) and occlusions of retinal arterial |
| Q40461814 | Lipoprotein disorders as related to atherosclerotic cardiovascular disease. |
| Q73480537 | Lipoprotein(a) in atrial fibrillation |
| Q72664924 | Lipoprotein(a) in nephrotic syndrome |
| Q39571335 | Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells. |
| Q73326758 | Lipoprotein(a) is related to the extent of lesions in the coronary vasculature and to unstable coronary syndromes |
| Q72595255 | Lipoprotein(a) levels in peripheral atherosclerotic disease |
| Q43535845 | Lipoprotein(a), Friedewald formula, and NCEP guidelines. National Cholesterol Education Program |
| Q45004490 | Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation |
| Q40521691 | Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention, and therapy. Coronary Artery Disease in Asian Indians (CADI) Study |
| Q40948177 | Metabolic abnormalities in cardiac ischemia. |
| Q33786866 | Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications |
| Q51568518 | Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents. |
| Q35182214 | Niacin and cholesterol: role in cardiovascular disease (review). |
| Q37205859 | Olmesartan Combined With Amlodipine on Oxidative Stress Parameters in Type 2 Diabetics, Compared With Single Therapies: A Randomized, Controlled, Clinical Trial |
| Q33740239 | Pathogenesis and pathology of coronary heart disease syndromes |
| Q35559549 | Plasma lipoprotein concentrations in ethnic populations |
| Q72809756 | Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival |
| Q47644677 | Premature Coronary Heart Disease in South Asians: Burden and Determinants |
| Q33986362 | Prevention of coronary artery disease |
| Q72389423 | Pulsed-field gel electrophoresis for the separation of large protein molecules exemplified by the isoforms of apolipoprotein (a) |
| Q42981013 | Resistance of lipoprotein(a) to lipid peroxidation induced by oxygenated free radicals produced by gamma radiolysis: a comparison with low-density lipoprotein |
| Q72554556 | Safety and efficacy of lifibrol upon four-week administration to patients with primary hypercholesterolaemia |
| Q40526165 | Selected aspects of ACE inhibitor therapy for patients with renal disease: impact on proteinuria, lipids and potassium |
| Q74052413 | Should lipoprotein(a) be measured in pediatric renal transplant recipients? |
| Q55066488 | Testosterone decreases lipoprotein(a) in men. |
| Q34229929 | The menopause and its treatment in perspective |
| Q58265908 | The relationship between plasma androgens (dehydroepiandrosterone sulfate and testosterone) and coronary arteriosclerosis in men: The lower the androgens, the higher the coronary score of arteriosclerosis |
| Q24793360 | The role of dyslipidemia and statins in venous thromboembolism |
| Q51544032 | The role of megestrol acetate as an alternative to conventional hormone replacement therapy. |
| Q40760251 | Transdermal estradiol/norethisterone. A review of its pharmacological properties and clinical use in postmenopausal women |
Search more.